Product Information (PI) is a sheet written for healthcare professionals (HPs, more specifically Australian HPs) that provides a summary of the scientific information that is relevant to the safe and effective use of the information the PI is written for.
It has the following sections:
- NAME OF THE MEDICINE[note 1]
- DESCRIPTION[note 2]
- CLINICAL TRIALS
- INDICATIONS[note 3]
- CONTRAINDICATIONS[note 4]
- PRECAUTIONS (the sections are not always in the below order)
- Special populations: Elderly, Pregnancy, Lactation, Children/Adolescents, Preexisting Medical Problems.
- Carcinogenicity, Mutagenicity, Impairment of Fertility
- Effects on driving
- Dietary restrictions (if applicable)
- INTERACTIONS WITH OTHER MEDICINES
- ADVERSE EFFECTS[note 5]
- DOSAGE AND ADMINISTRATION
- OVERDOSAGE[note 6]
- STORAGE[note 7]
- SPONSOR[note 8]
- Product Information sheets that are hosted by the TGA-eBS may be found for here . This picture  should help you in searching for the PI.
- ↑ Includes the structure of the drug, generic name, molecular formula, molar mass and IUPAC name
- ↑ Includes the physical and chemical properties of the drug and the appearance of the dosage form (e.g., tablets). Includes excipients (i.e., non-active ingredients in the dosage form).
- ↑ Medical uses
- ↑ These are pre-existing conditions or medicines that should be avoided in all circumstances
- ↑ Side effects, usually listed in their respective frequency; e.g., very common (occurring in ≥10% of patients), common (1%≤frequency<10%), uncommon (0.1%≤frequency<1%), rare (0.01%≤frequency<0.1%) and very rare (frequency<0.01%).
- ↑ What treatment is required in cases of overdose
- ↑ The storage conditions required to protect the drug from degradation
- ↑ The drug company that sponsors the drug's development and sale